Search
Now showing items 1-10 of 10
Polypharmacy in patients with Multiple Sclerosis: effects on fatigue, perceived cognition, and objective cognitive performance
(2013-06-24)
OBJECTIVE: Many individuals with multiple sclerosis (MS) take multiple medications on a regular basis, also referred to as polypharmacy. In other patient populations, polypharmacy has been associated with fatigue and ...
Biopsychosocial Comparison of Adherent and Nonadherent Multiple Sclerosis Patients
(2016)
OBJECTIVE: Between 30-50% of patients with relapsing remitting multiple sclerosis (RRMS)
prematurely discontinue disease modifying therapies (DMTs). Despite this, relatively little is known
about clinical factors that ...
Processing speed and working memory training in multiple sclerosis: a blinded randomized controlled trial
(2013)
Between 40-65% of patients with multiple sclerosis (MS) experience cognitive
deficits associated with the disease. The two most common areas affected are information
processing speed and working memory. Information ...
Theory of Mind in Multiple Sclerosis: Disease Subtype Differences and Association with Measures of Social Functioning
(2015-08-11)
Theory of mind (ToM) allows a person to make inferences about the mental and
emotional states of others. Generally, people with multiple sclerosis (MS) perform more
poorly on ToM tests than neurologically intact controls. ...
Assessing Social Motivations During Vaccination Decisions
(University of Missouri -- Kansas City, 2018)
This dissertation utilized two separate studies to investigate the effects of social
motivation during vaccine decision-making. Some parents cite social motivations, like
contributing to herd immunity, as an influence ...
Episodic Future Thinking in Young Children: Considering Body Mass and Memory
(2015-08-04)
With the increase in pediatric obesity, research continues to evaluate new intervention strategies to improve the effectiveness of current obesity treatments. One area of study which may hold promise for pediatric obesity ...
Mechanisms of Action in Motivational Interviewing
(2020)
Despite the demonstrated efficacy of disease modifying therapies (DMT), many MS patients (~ 40%) stop using DMT within 3 years of starting. A cross-over randomized controlled trial demonstrated that a theoretically based ...
Beliefs about the Impact of Excess Body Weight on Biopsychosocial Functioning in Multiple Sclerosis Patients
(University of Missouri--Kansas City, 2017)
Background: Recent research indicates that obesity may exacerbate certain symptoms
of Multiple Sclerosis (MS). Nevertheless, little research has examined patients’ perceptions
of how obesity may impact their MS symptoms. ...
A Double-Blind Randomized Intervention to Reduce Distress from Perceived Cognitive Impairment in Multiple Sclerosis
(University of Missouri -- Kansas City, 2019)
OBJECTIVE: Up to 65% of patients with multiple sclerosis (MS) experience cognitive impairment.
However, patients frequently overestimate the extent of their cognitive dysfunction, reducing their
overall quality of life. ...
Cognition, Fatigue, and Health-related Quality of Life in Multiple Sclerosis: Exploring the Role of Polypharmacy and Anticholinergic Medication Burden
(2022)
OBJECTIVE: Recent evidence suggests that polypharmacy, or the daily use of multiple medications, is common among individuals with multiple sclerosis (MS). Some medications have anticholinergic properties that increase risk ...